Investor Presentaiton

Investor presentation Full year 2018 Slide 79 The GLP-1 segment accounts for around 6% of the total diabetes care market in Region Japan & Korea DKK billion Region Japan & Korea GLP-1 market VictozaⓇ Exenatide Dulaglutide Other GLP-1 market value VictozaⓇ value market share in Region Japan & Korea VictozaⓇ Exenatide Dulaglutide Other Share of total diabetes care GLP-1 value market share market 1.8 4% 100% 1.6 1.4 CAGR value¹: 31.1% 80% 3% 1.2 60% 1.0 2% 0.8 40% 0.6 1% 0.4 20% 0.2 0.0 0% 0% Nov 2013 Nov Nov 2018 2013 1 CAGR for 5-year period Source: IQVIA monthly MAT Nov, 2018 value figures changing diabetes Source: IQVIA monthly MAT Nov, 2018 value figures. Market share does not add up to 100% due to rounding 61% 33% 4% 3% Nov 2018 novo nordisk

View entire presentation